The differences in AUCs between ER/PR+HER2− disease and HER2+ disease were statistically significant (all p-values < 0.009), but differences did not reach statistical significance for ER/PR+HER2− compared with ER/PR/HER2− (triple-negative breast cancer, TNBC). Here, ERBB2 is linked to triple-negative breast carcinoma.